A cost-effectiveness evaluation is performed comparing TAVI versus medical management. The economic evaluation should model the medical management treatment arm with and without balloon valvuloplasty, as these will have different weights and costs. The health benefits associated with TAVI over medical management +/- balloon valvuloplasty are likely to be improved quality of life and improved life expectancy. The decision analytic model will be structured as follows: Figure 2: Decision analytical model TAVI: transcatheter aortic valve implantation; SAVR: standard aortic valve replacement; TF: transfemoral; Proposed MBS item and fee The proposed medical service is likely to substitute standard aortic valve replacement in patients considered eligible by the heart team. Standard aortic valve replacement is already publicly funded under the following MBS items: 38488 and 38489. The proposed fee for the intervention is based on item 38488 replacement with bioprosthesis or ‘valve mechanical with a fee of $1,909.60 (as of 20 February 2014). prosthesis’
A cost-effectiveness evaluation is performed comparing TAVI versus medical management. The economic evaluation should model the medical management treatment arm with and without balloon valvuloplasty, as these will have different weights and costs. The health benefits associated with TAVI over medical management +/- balloon valvuloplasty are likely to be improved quality of life and improved life expectancy. The decision analytic model will be structured as follows: Figure 2: Decision analytical model TAVI: transcatheter aortic valve implantation; SAVR: standard aortic valve replacement; TF: transfemoral; Proposed MBS item and fee The proposed medical service is likely to substitute standard aortic valve replacement in patients considered eligible by the heart team. Standard aortic valve replacement is already publicly funded under the following MBS items: 38488 and 38489. The proposed fee for the intervention is based on item 38488 ‘valve replacement with bioprosthesis or mechanical prosthesis’ with a fee of $1,909.60 (as of 20 February 2014).
1361-TAVI-FinalProtocol-accessible.docx